Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire.
Standard
Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. / Augustin, M; Gajur, A I; Reich, C; Rustenbach, Stephan Jeff; Schaefer, I.
In: DERMATOLOGY, Vol. 217, No. 2, 2, 2008, p. 101-106.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire.
AU - Augustin, M
AU - Gajur, A I
AU - Reich, C
AU - Rustenbach, Stephan Jeff
AU - Schaefer, I
PY - 2008
Y1 - 2008
N2 - In addition to clinical efficacy, patient-defined benefit assessment has become an important outcome parameter. Thus far, no such instrument has been developed for vitiligo.
AB - In addition to clinical efficacy, patient-defined benefit assessment has become an important outcome parameter. Thus far, no such instrument has been developed for vitiligo.
KW - Humans
KW - Male
KW - Female
KW - Severity of Illness Index
KW - Reproducibility of Results
KW - Sensitivity and Specificity
KW - Feasibility Studies
KW - Quality of Life
KW - Psychometrics/statistics & numerical data
KW - Questionnaires
KW - Sickness Impact Profile
KW - Evaluation Studies as Topic
KW - PUVA Therapy
KW - Patient Participation
KW - Vitiligo/diagnosis/drug therapy/psychology
KW - Humans
KW - Male
KW - Female
KW - Severity of Illness Index
KW - Reproducibility of Results
KW - Sensitivity and Specificity
KW - Feasibility Studies
KW - Quality of Life
KW - Psychometrics/statistics & numerical data
KW - Questionnaires
KW - Sickness Impact Profile
KW - Evaluation Studies as Topic
KW - PUVA Therapy
KW - Patient Participation
KW - Vitiligo/diagnosis/drug therapy/psychology
M3 - SCORING: Journal article
VL - 217
SP - 101
EP - 106
JO - DERMATOLOGY
JF - DERMATOLOGY
SN - 1018-8665
IS - 2
M1 - 2
ER -
